Clearance Summary
360CAS received FDA 510(k) clearance under submission number K223927, sponsored by Kico Knee Innovation Company Pty Limited. The device was reviewed via the Special premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2023-01-27.
- Submission: K223927
- Applicant / Sponsor: Kico Knee Innovation Company Pty Limited
- Clearance pathway: Special
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.4560
- Decision date: 2023-01-27
Classification & Regulation
This clearance is catalogued under FDA product code OLO and 21 CFR 882.4560, within the Neurology review panel as a Class II device.